首页> 外文期刊>Quimica nova >Adenosine A3 receptors: a new therapeutic approach in cancer
【24h】

Adenosine A3 receptors: a new therapeutic approach in cancer

机译:腺苷A3受体:一种新的癌症治疗方法

获取原文
       

摘要

Cancer is a multi-factorial disease linked with different initiating causes, cofactors and promoters, and several types of cellular damage. Advancing knowledge on the cellular and molecular biology of the processes that regulate cell proliferation, cell differentiation and cellular responses to external signals, has provided a wealth of information about the cancer cell and how it differs from a normal one. These findings make available a number of potential targets for new therapeutic approaches. The Medicinal Chemistry artwork performed so far in the development of selective and potent adenosine receptor A3 ligands, a current cancer target, will be highlighted in this work.
机译:癌症是一种多因素疾病,与不同的起因,辅助因子和启动子以及几种类型的细胞损伤有关。关于调节细胞增殖,细胞分化和细胞对外部信号的反应的过程的细胞和分子生物学的先进知识,提供了有关癌细胞及其与正常细胞的区别的大量信息。这些发现为新的治疗方法提供了许多潜在的目标。迄今为止,在目前选择性的和有效的腺苷腺苷受体A3配体的开发过程中所进行的药物化学研究将在这项工作中得到重点介绍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号